VIDEO: Consider cost in anastrozole vs. tamoxifen for DCIS

CHICAGO – Anastrozole may top tamoxifen in reducing the risk of disease recurrence in postmenopausal ductal carcinoma in situ (DCIS), particularly in younger women, but which drug holds a cost...